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Angiotensin II (ANG II), a bioactive peptide well known to play an important role in
blood-pressure and body-fluid regulation, participates in inflammatory responses, too.
Recently, we reported results suggesting that ANG II is involved in the development of the
fever induced by intravenous (i.v.) injection of lipopolysaccharide (LPS, 2 µg/kg) in
dehydrated rats (in which the secretion of ANG II is elevated).  Furthermore, we verified
the contributions made by ANG II and its type 1 receptor (AT1 receptor) to the LPS-
induced production of interleukin-1β (IL-1β) in those rats.  It therefore seems likely that
in rats, ANG II and its receptors contribute to the induction of this fever at its 1st step
(namely, the LPS-induced production of pyrogenic cytokines such as IL-1β).  Moreover,
we have revealed that intrahypothalamic (i.h.) ANG II and AT2 receptors are involved in
the development of the fever induced by i.h. injection of prostaglandin E2 (PGE2), a final
fever mediator.  ANG II given i.h., which had no effect on the resting body temperature,
facilitated PGE2-nduced fever.  These results suggest that in rats, ANG II and its receptors
contribute to the induction of fever at its final step, too (namely, the action of PGE2 to
cause fever).  Finally, a single i.p. injection of IL-1β results in a weaker IL-1β-induced
fever in AT2-receptor-deficient mice than in wild-type mice, suggesting that the brain AT2
receptor is involved in the development of  fever (possibly at its final step) in mice as well.
Collectively, these results suggest that in rodents, ANG II and its receptors contribute to
the development of fever, both at the 1st and final steps in the pathway for fever induction.
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Abbreviations: ACE, angiotensin-converting-enzyme; aCSF, artificial cerebrospinal fluid; ANG II, angiotensin II;
AT1, ANG II type 1; i.c.v., intracerebroventricular; i.h., intrahypothalamic; IL-1β, interleukin-1β; i.p., intraperi-
toneally; i.v., intravenous; LPS, lipopolysaccharide; PGE2, prostaglandin E2; PO/AH preoptic/anterior hypothalamic
Angiotensin II (ANG II), a bioactive peptide well
known to play an important role in blood-pressure
and body-fluid regulation, seems to participate in
inflammatory responses, too.  For example, ANG II
and ANG-II-type-1 (AT1) receptors are involved in
certain types of cardiovascular inflammation (Usui
et al., 2000).  Furthermore, angiotensin-converting-
enzyme (ACE) inhibitors have an anti-inflamma-
tory effect (Delfraissy et al., 1984; Martin et al.,
1984; Rezkalla et al., 1990).  We recently revealed
that ANG II and its receptors are involved in the
development of fever (another example of an in-
flammatory response) both in rats (Watanabe et al.,
1997, 2000; Miyoshi et al., 2003) and in mice
(Watanabe et al., 1999).
This review focuses on the role of ANG II and
its receptors in the development of febrile responses
in rodents.
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Fig. 1.  Effect of intravenous (i.v.) injection of lisinopril on lipopolysaccharide (LPS)- or interleukin-1β (IL-1β)-
induced fever in dehydrated rats.  Changes (mean ± SEM) in body temperature (˚C) in dehydrated rats after i.v.
injection at time 0 of LPS (A:  2 µg/kg) or IL-1β (B:  2 µg/kg).  Lisinopril (10 mg/kg) was administered i.v. immedi-
ately before the injection of LPS or IL-1β.  [   ], number of subjects.  Data from Watanabe et al. (2000).
ANG II and Fever in Rats
It is widely accepted that once in the body, bacterial
endotoxin [or lipopolysaccharide (LPS)] stimulates
leukocytes to produce pyrogenic cytokines, such as
interleukin-1 (IL-1) or IL-6, leading to fever induc-
tion (Kluger, 1991; Dinarello, 1999).  Furthermore,
the febrile response to pyrogenic cytokines is be-
lieved to be mediated by prostaglandin E (PGE),
acting within the brain as a final fever mediator
(Blatteis and Sehic, 1997; Ushikubi et al., 2000).
We have reported that in rats, ANG II and its re-
ceptors contribute to the induction of fever not only
at its 1st step [namely, the LPS-induced production
of pyrogenic cytokines (Watanabe et al., 2000;
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Fig. 2.  Effect of i.v. injection of lisinopril on LPS-induced
increase in IL-1β mRNA expression in the liver in dehy-
drated rats.  IL-1β mRNA expression in the liver of “Saline
+ saline”, “Saline + LPS” and “Lisinopril + LPS” groups.
Lisinopril (20 mg/kg) or saline was administered i.v. 30
min before a single i.v. injection (at time 0) of LPS (2 µg/
kg) or saline in dehydrated rats.
A:  Autoradiograms showing IL-1β mRNA and β-actin
mRNA bands in a representative animal from each
group at 2h and 4h after “time 0”.
B:  Analysis of the density of the IL-1β mRNA bands in
each group.  Mean values (± SEM) obtained for IL-1β
mRNA in the liver are expressed in arbitrary units.  For
each sample, the density of the IL-1β mRNA fraction
was normalized with respect to the β-actin density.   [  ],
number of subjects.  Data from Miyoshi et al. (2003).
Miyoshi et al., 2003)] but also at its final step [name-
ly, the action of PGE2 to cause fever (Watanabe et
al., 1997)].  We should like to present our findings
below.
ANG II is involved in fever production in
rats at its 1st step, the LPS-induced produc-
tion of IL-1β
It is well known that a host develops a higher fever
under dehydrated conditions than under euhydrated
conditions.  Indeed, in our hands, i.v. injection of a
given dose of LPS induced a fever that was signifi-
cantly greater in dehydrated rats than in euhydrated
rats.  However, dehydration had no effect on the
fever induced by i.v. injection of IL-1β (Watanabe
et al., 2000).  These results suggested that the LPS-
induced production of pyrogenic cytokines such as
IL-1β might be enhanced by dehydration.  Further-
more, since the secretion of ANG II increases under
dehydrated conditions it seemed possible that ANG
II might be involved in this enhanced production of
pyrogenic cytokines, and ultimately in enhancing
the fever seen in response to LPS.  To test this pos-
sibility, we examined the effect of an angiotensin-
converting-enzyme (ACE) inhibitor on febrile re-
sponses in dehydrated rats.
Figure 1 illustrates the effect of the ACE in-
hibitor lisinopril on the fever induced in dehydrated
rats by an i.v. injection of LPS (2 µg/kg) (Watanabe
et al., 2000).  When lisinopril was given i.v. just be-
fore the LPS, the LPS-induced fever was signifi-
cantly attenuated (Fig. 1A), indicating that ANG II
is indeed involved in LPS-induced fever in dehy-
drated rats.  In contrast, the same inhibitor had no
effect on the fever induced by IL-1β itself (Fig. 1B),
suggesting that ANG II may act by contributing to
the LPS-induced production of pyrogenic cytokines,
such as IL-1β.
To test the above possibility, we then examin-
ed the effect of lisinopril on the expression of IL-1β
mRNA in the liver of dehydrated rats given an i.v.
injection of LPS.  Animals were sacrificed, the liver
quickly removed and its IL-1β mRNA examined by
Northern blot analysis.  As shown in Fig. 2, LPS
induced a significant increase in the expression of
hepatic IL-1β mRNA at both 2 and 4 h after its in-
jection, and this increase was reduced by treatment
with lisinopril (Fig. 2A), an effect that, by quantita-
tive analysis, was revealed to be statistically signifi-
cant (Fig. 2B) (Miyoshi et al., 2003).  This result
suggested that ANG II contributes to the LPS-
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Fig. 3.  Effect of i.v. injection of lisinopril on LPS-induced
increase in liver concentration of IL-1β protein in dehy-
drated rats.  Changes (mean ± SEM) in liver concentration
of IL-1β in dehydrated rats 2 and 4 h after i.v. injection of
LPS (2 µg/kg).  Lisinopril (20 mg/kg) or saline was admin-
istered i.v. 30 min before a single i.v. injection (at time 0) of
LPS (2 µg/kg) or saline.   [  ], number of subjects.  Data from
Miyoshi et al. (2003).
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induced induction of IL-1β at the mRNA level in
dehydrated rats.
Next we investigated the effect of lisinopril on
the production of IL-1β protein in the liver of de-
hydrated rats given an i.v. injection of LPS, the he-
patic concentration of IL-1β being measured by
enzyme-linked immunosorbent assay.  The results
are depicted in Fig. 3.  The LPS-induced increase in
the IL-1β protein concentration was significantly
attenuated by lisinopril at both 2 and 4 h after the
injection of LPS (Miyoshi et al., 2003).  Further-
more, it should be mentioned that i.v. injection of
ANG type 1 (AT1) receptor antagonist reduced this
LPS-induced IL-1β response in the liver as well
(Miyoshi et al., 2003).
Taken together, the above results made it seem
likely that ANG II and the AT1 receptor are in-
volved in the peripheral IL-1β production induced
in dehydrated rats by LPS.
ANG II is also involved in fever production in
rats at its final step, the action of PGE2 within
the brain to induce fever
Recently, we suggested that ANG II and its recep-
tors within the brain participate in the development
of one particular type of body-temperature increase,
namely stress-induced hyperthermia (Saiki et al.,
1997).  Two types of ANG II receptors are present
within the brain, AT1 and AT2 receptors (Saavedra,
1994; Wright and Harding, 1994; Aguilera et al.,
1995; Watanabe et al., 1998) and we have shown
that the brain AT1 receptor is the one responsible
for the induction of restraint-stress-induced hyper-
thermia in rats (Saiki et al., 1997).  We therefore
decided to investigate the effect of an intracerebro-
ventricular (i.c.v.) injection of the AT1-receptor
antagonist losartan (60 µg) on the febrile responses
induced in rats by an i.c.v. injection of PGE2 (200
ng), a final fever mediator (Blatteis and Sehic,
1997; Ushikubi et al., 2000).  We postulated that
AT1 receptors play an important role in this type of
fever, too.  Surprisingly, however, i.c.v. treatment
with losartan (60 µg) had no effect on the febrile
response induced by PGE2.  This dose of losartan
(60 µg) is actually rather high, because less than 10
µg of the drug is sufficient to inhibit ANG II-induced
responses such as increases in water intake
(Rowland et al., 1992) and arterial blood pressure
(Hogarty et al., 1992) in rats.  Thus, since it seemed
that AT1 receptors are not involved in PGE2-induced
fever, even though they participate in stress-induced
hyperthermia, we hypothesized that the other ANG
receptor, the AT2 receptor, might contribute to the
development of PGE2-induced fever.  Indeed, we
found that when an AT2-receptor antagonist, CGP
42112A (20 µg), was administered i.c.v. just before
i.c.v. PGE2, the fever was significantly reduced
(Watanabe et al., 1997).  This result suggested that
AT2 receptors located somewhere in the brain con-
tribute to the induction of fever by PGE2.
To try to determine where in the brain these
AT2 receptors might be situated, we gave intra-
hypothalamic (i.h.) injections of CGP 42112A and
observed their effects on fevers, because the rostral
hypothalamus is thought to be the site at which
PGE2 acts to induce fever.  For these i.h. injections,
a stainless-steel cannula was implanted into the pre-
optic/anterior hypothalamic (PO/AH) region on one
side at AP 1.8 mm, L 1.2 mm, and V 8.5 mm
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Fig. 5.  Effect of i.h. injection of ANG II on PGE2-induced fever
in rats.  Changes (mean ± SEM) in body temperature (˚C) in rats
after i.h. injection at time 0 of PGE2 (25 ng).  ANG II (25 ng, n =
8) or aCSF (n = 8) was administered i.h. immediately before the
injection of PGE2.  Data from Watanabe et al. (1997).
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Fig. 4.  Effect of intrahypothalamic (i.h.) injection of CGP
42112A on prostaglandin E2 (PGE2)-induced fever in rats.
Changes (mean ± SEM) in body temperature (˚C) in rats after i.h.
injection at time 0 of PGE2 (100 ng).  CGP 42112A (2 µg, n = 11;
or 5 µg, n = 8) or aCSF (n = 9) was administered i.h. immediately
before the injection of PGE2.  Also shown is the effect on resting
body temperature produced by CGP 42112A (5 µg i.h., n = 6)
given alone at time 0.  Data from Watanabe et al. (1997).
[coordinates from the rat brain atlas of
Pellegrino et al. (1979)] under sodium
pentobarbitone anaesthesia (50 mg/kg, i.p.).
Figure 4 shows the effects of i.h. in-
jections of CGP 42112A on the fever in-
duced by PGE2 (Watanabe et al., 1997).  In
artificial cerebrospinal fluid (aCSF)-treated
controls, injection of PGE2 (100 ng, i.h)
resulted in a monophasic fever, the body
temperature beginning to increase immedi-
ately and reaching peak at 25 min.  This fe-
brile response was attenuated by i.h. treat-
ment with CGP42112A (2 and 5 µg) in a
dose-related manner, the effect being signif-
icant at P < 0.05 [for CGP42112A (5 µg) +
PGE2, 0–40 min] (Fig. 4).  CGP42112A (5
µg, i.h.) given alone had no effect on resting
body temperature (Fig. 4).
These results suggest that AT2 re-
ceptors in the rostral hypothalamus (PO/AH
region) are involved in PGE2-induced fe-
brile responses in rats.
The question then arose as to whether
ANG II mediates or, on the other hand,
modulates febrile responses through its
action on AT2 receptors.  To clarify this
point, ANG II alone was administered into
the rostral hypothalamus to observe its ef-
fect on resting body temperature.  The re-
sults showed that ANG II, given i.h. at 25 ng
or 5 µg, did not exert any significant effects
on body temperature in rats (Watanabe et
al., 1997).  It therefore seems unlikely that
ANG II mediates the induction of fever in
rats; rather, ANG II is more likely to modu-
late the fevers induced by other agents.
Having found that ANG II at a dose of 25 ng
i.h. had no effect on resting body tempera-
ture, we used this dose to investigate whe-
ther ANG II modulates the fever induced by
PGE2.  As shown in Fig. 5, this dose of ANG
II, which had no effect on resting body tem-
perature, enhanced the PGE2-induced fever
(Watanabe et al., 1997), suggesting that
centrally acting ANG II modulates PGE2-
induced fever in rats.
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Fig. 6.  Febrile responses induced in control and AT2-receptor-deficient mice by intraperitoneal (i.p.) injection of IL-
1β.  Changes (mean ± SEM) in body temperature in control and AT2-receptor-deficient mice after i.p. injection of IL-
1β (10 µg/kg).   [   ], number of subjects.  Data from Watanabe et al. (1999).
Finally, we investigated the effects of an i.h.
injection of an ACE inhibitor, lisinopril, on PGE2-
induced fever in rats.  Lisinopril (5 or 10 µg, i.h.) or
aCSF was given to rats 15 min before an injection
of PGE2 (100 ng, i.h.).  The results showed that
treatment with lisinopril reduced the PGE2-induced
fever in a dose-related fashion (Watanabe et al.,
1997).  Lisinopril (10 µg, i.h.) given alone had no
marked effect on the resting body temperature.
Thus, inhibition of ANG II synthesis within the
rostral hypothalamus resulted in an attenuation of
PGE2-induced fever.
Taken together, our results suggest that in the
rat, hypothalamic ANG II, which is synthesized and
released in response to PGE2, acts on AT2 receptors
located within the hypothalamus to facilitate PGE2-
induced fever.  Interestingly, there are published re-
ports indicating that AT2 receptors are present in the
rostral hypothalamus (Lenkei, et al., 1996; Lenkei,
et al., 1997).  Moreover, using microdialysis (perfu-
sion flow rate = 2 µL/min and recovery rate = 14.2%)
we recently found that i.h. perfusion with PGE2 (2
µg/2 µL perfusate/min) resulted in ANG II release
(on average, 0.17 pg/2 µL perfusate/min; n = 3)
within the rat’s rostral hypothalamus (unpublished
observations).
ANG II and Fever in Mice
Recently, 2 laboratories developed mice deficient
in AT2 receptors that showed increased pressor
responses to ANG II and a lower than normal body
temperature (Hein et al., 1995; Ichiki et al., 1995).
These mice also exhibit attenuated exploratory be-
havior and reduced spontaneous movements, sug-
gesting that endogenous ANG II and AT2 receptors
regulate brain functions.  We administered IL-1β
intraperitoneally (i.p.) to AT2-receptor-deficient
mice to allow us to compare the febrile response in
such mice with that in wild-type mice.  As shown in
Fig. 6, in the controls a single injection of IL-1β (10
µg/kg, i.p.) resulted in a biphasic fever which began
after 5 min and reached its 1st peak at 15 to 20 min
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(Watanabe et al., 1999).  The 2nd peak occurred at
around 60 min.  The 1st phase involves an injection-
stress-induced hyperthermia, while the 2nd phase is
a true IL-1β fever.  This IL-1β fever was suppressed
in the AT2-receptor-deficient mice, the effect being
significant at P < 0.05 (25–180 min), while there
was no difference in the 1st phase of the
hyperthermia between the 2 groups of mice.  The
body temperature of the mutant mice was similar to
that of the controls from 150 min onwards.
These results suggest that in mice, the pathway
distal to the point at which IL-1β acts involves an
action of ANG II on AT2 receptors.  Since in rats cen-
tral injection of an AT2-receptor antagonist attenu-
ates PGE2-induced fever [see above (Watanabe et
al., 1997)], it is likely that the brain AT2 receptor is
important in the induction of PGE2-induced fever in
mice as well in rats.  However, it should be noted in
the above results that an attenuation of the IL-1β
fever was observed only during the early stage of
the hyperthermia (10–180 min).  Therefore, it may
be that the AT2 receptor is just one of a number of
factors contributing to IL-1β fever, and that its im-
portant role is performed mainly during the rising
phase of this fever.
Concluding  Remarks
In this mini-review, we have focussed on the role of
ANG II in the development of fever in rats and
mice.
We have shown that an i.v. injection of LPS
induces a fever that is significantly greater in
“dehydrated” than in “euhydrated” rats (Morimoto
et al., 1986; Watanabe et al., 1997).  We have sug-
gested i) that the LPS-induced production of pyro-
genic cytokines such as IL-1β might be enhanced
by dehydration and ii) that ANG II is involved in
this enhanced production of pyrogenic cytokines,
and ultimately in enhancing the fever seen in re-
sponse to LPS.  Indeed, an ACE inhibitor inhibited
the LPS-induced production of hepatic IL-1β, as
well as the fever, in dehydrated rats (Watanabe et
al., 2000; Miyoshi et al., 2003).
It is widely accepted that PGE2 acts within the
rostral hypothalamus to induce fever, as a final
mediator (Blatteis and Sehic, 1997; Ushikubi et al.,
2000).  We found that i.h. injection of either an
AT2-receptor antagonist or an ACE inhibitor inhib-
ited the fever induced by an i.h. injection of PGE2.
Furthermore, ANG II given i.h., which had no ef-
fect on the resting body temperature, facilitated
PGE2-induced fever (Watanabe et al., 1997).  These
results suggest that hypothalamic ANG II, follow-
ing its synthesis and release in response to PGE2,
acts on AT2 receptors in the rat hypothalamus to
facilitate PGE2-induced fever.
Finally, when we gave a single i.p. injection of
IL-1β to AT2-receptor-deficient mice we found that
the IL-1β-induced fever was significantly weaker
than in the wild-type mice, suggesting that the brain
AT2 receptor is involved in the development of such
fever in mice as well.
Taken together, the observations reviewed
here make it seem likely that ANG II contributes to
the development of fever by acting at both the 1st
and final steps in the pathway for fever-induction in
rodents.
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